Manabu Hori

Title: The Innovative Contributions of Manabu Hori

Introduction

Manabu Hori is a notable inventor based in Osaka-fu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address critical health issues. With a total of 2 patents to his name, Hori's work is recognized for its potential impact on medical treatments.

Latest Patents

Hori's latest patents include a 1,4-benzoxazine derivative and pharmaceutical compositions containing it. This compound is designed to serve as a medicament for preventing or treating disorders induced by intracellular acidosis during myocardial ischemia. Such disorders include cardiac dysfunction, myocardial necrosis, arrhythmia, and reperfusion injury, which are commonly observed in ischemic heart diseases like myocardial infarction and angina pectoris. Another significant patent involves a quinazoline derivative, which is represented by a specific formula. This compound is intended to be used as a cerebral dysfunction remedying agent, showcasing Hori's commitment to addressing complex medical challenges.

Career Highlights

Manabu Hori is currently associated with Kanebo, Limited, where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a focus on developing effective treatments for serious health conditions, reflecting his dedication to improving patient outcomes.

Collaborations

Hori has collaborated with notable colleagues, including Hiroshi Ohtaka and Ryuichi Iemura. These partnerships have likely enhanced the scope and impact of his research, fostering an environment of innovation and shared expertise.

Conclusion

In summary, Manabu Hori is a distinguished inventor whose work in pharmaceuticals has the potential to significantly improve medical treatments. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.